WHO ICTRP trial
A real world study to evaluat the efficacy of Beifanluoer on sexual function in…
ChiCTR2200062201 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200062201 |
|---|---|
| Public title | A real world study to evaluat the efficacy of Beifanluoer on sexual function in young and middle-aged men with hypertension |
| Scientific title | A real world study to evaluat the efficacy of Beifanluoer on sexual function in young and middle-aged men with hypertension |
| Primary sponsor | The First Affiliated Hospital of He'nan University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | Hypertension |
| Interventions | Experimental group:Bevanolol hydrochloride tablets |
| Registration date | Jul 29, 2022 |
| Target size | Experimental group:200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: